Johnson & Johnson (JNJ) Invested Capital (2009 - 2026)

Johnson & Johnson has disclosed Invested Capital across 18 years of filings, most recently posting $98.6 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $98.6 billion, up 7.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.6 billion (up 7.22% YoY), and the FY2025 annual result was $123.0 billion, up 18.38% from the prior year.
• Invested Capital came in at $98.6 billion for Q1 2026 at Johnson & Johnson, down from $123.0 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $123.0 billion in Q4 2025 to a low of $74.6 billion in Q3 2024.
• The 5-year median for Invested Capital is $88.5 billion (2023), against an average of $90.3 billion.
• Across the five-year window, Invested Capital fell 11.57% in 2024 and rose 18.38% in 2025, its largest moves.
• Johnson & Johnson's Invested Capital stood at $79.0 billion in 2022, then increased by 21.64% to $96.1 billion in 2023, then advanced by 8.08% to $103.9 billion in 2024, then increased by 18.38% to $123.0 billion in 2025, then slipped by 19.79% to $98.6 billion in 2026.
• The last three Invested Capital figures came in at $98.6 billion (Q1 2026), $123.0 billion (Q4 2025), and $85.7 billion (Q3 2025), per Business Quant data.